Abstract

Carbonic anhydrases (CAs) are thought to be important for regulating pH in the tumor microenvironment. A few of the CA isoforms are upregulated in cancer cells, with only limited expression in normal cells. For these reasons, there is interest in developing inhibitors that target these tumor-associated CA isoforms, with increased efficacy but limited nonspecific cytotoxicity. Here we present some of the biophysical, biochemical, and cell based techniques and approaches that can be used to evaluate the potency of CA targeted inhibitors and decipher the role of CAs in tumorigenesis, cancer progression, and metastatic processes. These techniques include esterase activity assays, stop flow kinetics, and mass inlet mass spectroscopy (MIMS), all of which measure enzymatic activity of purified protein, in the presence or absence of inhibitors. Also discussed is the application of X-ray crystallography and Cryo-EM as well as other structure-based techniques and thermal shift assays to the studies of CA structure and function. Further, large-scale genomic and proteomic analytical methods, as well as cell based techniques like those that measure cell growth, apoptosis, clonogenicity, and cell migration and invasion, are discussed. We conclude by reviewing approaches that test the metastatic potential of CAs and how the aforementioned techniques have contributed to the field of CA cancer research.

Highlights

  • The role of Carbonic anhydrases (CAs) in different human disease states has been studied for many decades [1,2,3]

  • Recent advances in the field of CA research show that they may play an important role in the process of tumorigenesis, cancer progression, and metastasis [10,11,12,13,14,15,16,17,18,19,20]

  • We focus on some of the biophysical, biochemical, and cell based approaches currently studied to evaluate the potency of CA targeted inhibitors and to decipher the role of CAs in cancer

Read more

Summary

Introduction

The role of CAs in different human disease states has been studied for many decades [1,2,3]. CA targeting inhibitors are being tested in preclinical models for the treatment of diabetes and obesity, while others are currently in clinical trials as cancer therapies [4,5,6,7,8,9,10,11] Combined, these studies show that CAs are important therapeutic targets for the treatment of an expanding array of human diseases. Other approaches that will be discussed include large-scale gene and protein expression, measure metabolism, pH regulation, cell growth, migration, and invasion (Figure 2) Together, these methods will hopefully reveal the role of CAs in tumorigenesis, cancer progression, and metastasis

Enzymatic Assays and Biophysical Methods
Biophysical Methods
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call